Liebman Ronald MD - 08402 Margate City, NJ

Business Name: Liebman Ronald MD
Categorized In: Physicians Offices
Address: 7 South Vendome Avenue, Margate City, NJ 08402
Phone Number: (609) 822-8040
Contact Person: Ronald Liebman
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 2007
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Jay Hirsh Md - Margate City, NJ 08402
Salzman Albert J MD - Margate City, NJ 08402
Eric W Fine Md - Margate City, NJ 08402
Wm H Axelrod Dr - Margate City, NJ 08402
Michael S Feldman Md - Margate City, NJ 08402
Sidney Rubenstein Dr - Margate City, NJ 08402
Bernard Rossman Md - Margate City, NJ 08402
Silverman William MD - Margate City, NJ 08402
Zakuto Alan S MD - Margate City, NJ 08402
Krane Marvin A MD - Margate City, NJ 08402
Batastini Paul MD - Margate City, NJ 08402
Leonardo Magran Md - Margate City, NJ 08402
Meshkov Stanley MD - Margate City, NJ 08402
Hankin Samuel MD - Margate City, NJ 08402
Edwin H Mcknight Md - Margate City, NJ 08402
Jos M Kane Dr - Margate City, NJ 08402
Joseph Altomonte Md - Margate City, NJ 08402
Earl Kanter Md - Margate City, NJ 08402
June F Klinghoffer Md - Margate City, NJ 08402
Richard Cohen Assoc - Margate City, NJ 08402

Liebman Ronald MD provides professional Physicians Offices from its single location at the coordinates 39.32382,-74.51076.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 2007, the company can now be visited at 7 South Vendome Avenue, Margate City, New Jersey 08402 or contacted through representative Ronald Liebman at (609) 822-8040.

For frequently asked questions and further inquiries about professional Physicians Offices, get to know more about Liebman Ronald MD through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.